Polycystic Kidney Disease Clinical Trials

Find Polycystic Kidney Disease Clinical Trials Near You

Short-Term Metabolic Impacts of Ren-Nu: A Dietary Program for Individuals With Polycystic Kidney Disease

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a 16 week pilot study of the impact of a nutritionist led ketogenic diet (Ren-Nu) supplemented with the medical food KetoCitra on autosomal dominant polycystic kidney disease.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult (18 years or older)

‣ Diagnosis of ADPKD by a physician.

⁃ Estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73 m2 at screening using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.

⁃ Appropriate control of blood pressure (i.e. entry reading \<140/90) including the use of BP medications for diagnosis of hypertension.

⁃ BMI ≥ 25 (accounting for muscle mass)

⁃ Own an at-home blood pressure monitor (no brand requirements)

⁃ Able to complete study-related activities (e.g., attend online classes, complete questionnaires, and proper use of medical devices)

Locations
United States
Ohio
Cleveland Clinic
RECRUITING
Cleveland
Contact Information
Primary
Chloe Booth
boothc2@ccf.org
216-444-5053
Backup
Richard Fatica, MD
faticar@ccf.org
216-445-9953
Time Frame
Start Date: 2026-02-25
Estimated Completion Date: 2028-02
Participants
Target number of participants: 20
Treatments
Experimental: Pilot study on ketogenic diet Ren-Nu and KetoCitra supplement on ADPKD
Nutritional counseling and instruction in a ketogenic diet and nutritional food supplement
Sponsors
Leads: Richard Fatica
Collaborators: Santa Barbara Nutrients

This content was sourced from clinicaltrials.gov